Stockreport

Kymera Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 64%. Earnings per share (EPS) exceeded analyst est [Read more]